First Warning Systems, the Reno, Nevada-based company that’s working on wearable sensors for early detection of breast cancer, has raised $560,000, according to CEO Rob Royea. Steven Welch, a private investor and former COO of BP (not to be confused with DreamIt Health founder Steve Welch) led the round with a $300,000 contribution. The rest came from a syndicate of investors in Singapore, where First Warning intends to launch its product in early 2015...Starting in July, two clinical trials will be conducted with the device. Dr. William Farrar, will lead one study at the JamesCare Breast Center at The Ohio State University. The other study, led by Dr. Josh Ellenhorn at Cedars-Sinai Medical Center in Los Angeles, will be a multisite study, that also includes El Camino Hospital in Mountain View, California.
Read the entire article on the MobiHealthNews website